These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Perspectives on therapeutic interventions in patients with acute myocardial infarction: viewpoints after the GISSI-2 results. Maggioni AP; Franzosi MG; Malacrida R; Tognoni G Clin Cardiol; 1991 Jul; 14(7):549-56. PubMed ID: 1747963 [No Abstract] [Full Text] [Related]
28. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594 [TBL] [Abstract][Full Text] [Related]
29. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA). Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130 [TBL] [Abstract][Full Text] [Related]
30. Significance of initial ST segment changes for thrombolytic treatment in first inferior myocardial infarction. Schröder K; Wegscheider K; Neuhaus KL; Tebbe U; Schröder R Heart; 1997 Jun; 77(6):506-11. PubMed ID: 9227292 [TBL] [Abstract][Full Text] [Related]
31. GUSTO, TIMI and the case for rapid reperfusion. Cannon CP; Braunwald E Acta Cardiol; 1994; 49(1):1-8. PubMed ID: 8184639 [No Abstract] [Full Text] [Related]
32. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? Collen D Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781 [TBL] [Abstract][Full Text] [Related]
34. Thrombolytic therapy for acute myocardial infarction in older patients. Higgins S; Elliot C; Sandler DA Lancet; 1996 Apr; 347(9007):1054. PubMed ID: 8606604 [No Abstract] [Full Text] [Related]
35. [The effect of fibrinolysin and streptokinase preparations on the course and prognosis of acute myocardial infarction]. Pavlov AV; Iankin VV; Chausovskiĭ GM; Bokarev IN Klin Med (Mosk); 1991 Nov; 69(11):35-8. PubMed ID: 1839691 [No Abstract] [Full Text] [Related]
36. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction. Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008 [TBL] [Abstract][Full Text] [Related]
37. [Relation between the systemic fibrinolytic status and coronary reperfusion during thrombolytic therapy with streptokinase of patients with acute myocardial infarction]. Markov VA; Stoliarov VA; Varvarenko VI; Cherniavskaia LI; Karpov RS Kardiologiia; 1989 Sep; 29(9):92-4. PubMed ID: 2593482 [No Abstract] [Full Text] [Related]
38. Threatened reinfarction. Effective therapy using streptokinase with reversal of cardiogenic shock. Andrews WR; Arnold JM; Sibbald WJ Chest; 1990 Aug; 98(2):495-7. PubMed ID: 2376188 [TBL] [Abstract][Full Text] [Related]